This database study of the ultra-rare disease, HAE, conducted from January 2011 until December 2021 is the first of its kind to describe the characteristics of patients with HAE-C1-INH treated with danazol within the SUS and yielded interesting findings. The gene discussed is SERPING1; the disease is hereditary angioedema.